With Fevertree still priced at growth stock valuations, it pays to be cautious.

The agreement has been structured as a licence deal, with Fever-Tree receiving royalty fees based on its share of the profit generated in the US (with minimum payments guaranteed for five years).

Berenberg hiked its target price for tonic maker Fever-Tree from 700.0p to 860.0p on the back of the tonic maker's ...

Fevertree Drinks' recent strategic partnership with Molson Coors is set to accelerate its growth in the U.S. See why FQVTF ...

Fever-Tree is already the largest tonic and ginger beer brand in the US by value: but the brand believes there’s still huge ...

Molson Coors will pay £71m ($88m) for an 8.5% stake in Fever-Tree Drinks Plc: a deal which sent Fever-Tree shares soaring ...

A deal with a brewer on Molson Coors’ scale is transformational. Elevated glass and transatlantic freight costs have dragged ...

The Mediterranean and another cocktail on the menu, the whisky-based “Square Root” are infused with tea infusions that are ...

The Coors Light manufacturer’s 8.5% stake in the nonalcoholic carbonated mixer further builds on its long-term strategy of ...

With Lunar New Year having just passed, now is the time to raise a glass to the starting of a new year -- and we've got just ...

The term Galentine’s Day was first coined in an episode of the comedy TV series Parks and Recreation. Not that we need a ...